Sanofi (SNY) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SNY Stock Alerts $49.36 +2.75 (+5.90%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Sanofi Short Interest DataCurrent Short Volume3,240,000 sharesPrevious Short Volume3,900,000 sharesChange Vs. Previous Month-16.92%Dollar Volume Sold Short$149.82 millionShort Interest Ratio / Days to Cover1.6Last Record DateApril 15, 2024Outstanding Shares2,529,610,000 sharesShort Percent of Float0.13%Today's Trading Volume6,469,805 sharesAverage Trading Volume1,968,528 sharesToday's Volume Vs. Average329% Short Selling Sanofi ? Sign up to receive the latest short interest report for Sanofi and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNY Short Interest Over TimeSNY Days to Cover Over TimeSNY Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Sanofi Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,240,000 shares $149.82 million -16.9%0.1%1.6 $46.24 3/31/20243,900,000 shares $189.54 million -15.0%0.2%2.1 $48.60 3/15/20244,590,000 shares $221.65 million +6.5%0.2%2.6 $48.29 2/29/20244,310,000 shares $206.23 million +6.2%0.2%2.4 $47.85 2/15/20244,060,000 shares $188.34 million -10.6%0.2%2.4 $46.39 1/31/20244,540,000 shares $226.55 million -19.7%0.2%2.6 $49.90 Get the Latest News and Ratings for SNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,650,000 shares $294.99 million +22.3%0.2%2.8 $52.21 12/31/20234,620,000 shares $229.75 million +3.4%0.2%2.3 $49.73 12/15/20234,470,000 shares $213.13 million +13.7%0.2%2.1 $47.68 11/30/20233,930,000 shares $183.73 million +5.4%0.2%1.9 $46.75 11/15/20233,730,000 shares $169.42 million -25.4%0.2%1.9 $45.42 10/31/20235,000,000 shares $226.25 million +10.1%0.2%2.6 $45.25 10/15/20234,540,000 shares $247.57 million -0.4%0.2%3.1 $54.53 9/30/20234,560,000 shares $244.60 million +24.6%0.2%3.3 $53.64 9/15/20233,660,000 shares $199.62 million +7.0%0.2%3 $54.54 8/31/20233,420,000 shares $181.88 million +1.2%0.1%2.8 $53.18 8/15/20233,380,000 shares $178.46 million -18.9%0.1%2.7 $52.80 7/31/20234,170,000 shares $222.55 million -8.6%0.2%3.2 $53.37 7/15/20234,560,000 shares $240.22 million -6.6%0.2%3.5 $52.68 6/30/20234,880,000 shares $263.03 million +15.1%0.2%3.5 $53.90 6/15/20234,240,000 shares $219.59 million +11.3%0.2%2.7 $51.79 5/31/20233,810,000 shares $194.39 million +3.3%0.2%2.3 $51.02 5/15/20233,690,000 shares $201.25 million +2.8%0.2%2.1 $54.54 4/30/20233,590,000 shares $192.60 million No Change0.1%2 $53.65 4/15/20233,590,000 shares $201.58 million +23.4%0.1%1.9 $56.15 3/31/20232,910,000 shares $158.36 million +5.1%0.1%1.4 $54.42 3/15/20232,770,000 shares $131.77 million +1.1%0.1%1.4 $47.57 2/28/20232,740,000 shares $128.37 million +16.1%0.1%1.2 $46.85 2/15/20232,360,000 shares $111.51 million -12.9%0.1%1 $47.25 1/31/20232,710,000 shares $133.17 million -8.5%0.1%1.1 $49.14 1/15/20232,960,000 shares $145.84 million +6.9%0.1%1.1 $49.27 12/30/20222,770,000 shares $134.15 million -2.5%0.1%1 $48.43 12/15/20222,840,000 shares $133.93 million +11.4%0.1%0.9 $47.16 11/30/20222,550,000 shares $115.64 million -45.0%0.1%0.8 $45.35 11/15/20224,640,000 shares $202.07 million -12.6%0.2%1.6 $43.55 10/31/20225,310,000 shares $229.55 million +7.3%0.2%1.5 $43.23 10/15/20224,950,000 shares $195.92 million +34.2%0.2%1.5 $39.58 9/30/20223,690,000 shares $140.29 million -5.6%0.2%1.2 $38.02 9/15/20223,910,000 shares $159.02 million -18.4%0.2%1.3 $40.67 8/31/20224,790,000 shares $196.53 million +25.7%0.2%1.7 $41.03Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> SNY Short Interest - Frequently Asked Questions What is Sanofi's current short interest? Short interest is the volume of Sanofi shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 3,240,000 shares of SNY short. 0.13% of Sanofi's shares are currently sold short. Learn More on Sanofi's current short interest. What is a good short interest ratio for Sanofi? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNY shares currently have a short interest ratio of 2.0. Learn More on Sanofi's short interest ratio. Which institutional investors are shorting Sanofi? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Sanofi: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Sanofi? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of Sanofi's floating shares are currently sold short. Is Sanofi's short interest increasing or decreasing? Sanofi saw a decline in short interest in April. As of April 15th, there was short interest totaling 3,240,000 shares, a decline of 16.9% from the previous total of 3,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sanofi's short interest compare to its competitors? 0.13% of Sanofi's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Sanofi: Vertex Pharmaceuticals Incorporated (1.56%), Bristol-Myers Squibb (1.69%), Regeneron Pharmaceuticals, Inc. (1.27%), Pfizer Inc. (1.20%), GSK plc (0.36%), Zoetis Inc. (0.70%), Abbott Laboratories (0.75%), Novartis AG (0.19%), Takeda Pharmaceutical Company Limited (0.19%), Biogen Inc. (2.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Sanofi stock? Short selling SNY is an investing strategy that aims to generate trading profit from Sanofi as its price is falling. SNY shares are trading up $2.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sanofi? A short squeeze for Sanofi occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNY, which in turn drives the price of the stock up even further. How often is Sanofi's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VRTX Short Interest Data BMY Short Interest Data REGN Short Interest Data PFE Short Interest Data GSK Short Interest Data ZTS Short Interest Data ABT Short Interest Data NVS Short Interest Data TAK Short Interest Data BIIB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings